Showing results (1-10 of 20,422) with videos related to
Sort By:
Pageof 2,043
Expert Opinion on Emerging Drugs|April 26, 2006
Antisense-based cancer therapeutics: are we there yet?Elizabeth Rose Rayburn, Hui Wang, Ruiwen ZhangCurrent Pharmaceutical Design|August 17, 2005
Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeuticsHui Wang, Elizabeth Rayburn, Ruiwen ZhangCurrent Cancer Drug Targets|February 22, 2005
Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanismsRuiwen Zhang, Hui Wang, Sudhir AgrawalClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of actionJunmei Hou, Disong Wang, Ruiwen Zhang, et al.The Prostate|January 9, 2003
Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanismsHui Wang, Dong Yu, Sudhir Agrawal, et al.Anticancer Research|May 23, 2002
Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiformeGautam Prasad, Hui Wang, Sudhir Agrawal, et al.Current Cancer Drug Targets|February 22, 2005
MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapyElizabeth Rayburn, Ruiwen Zhang, Jie He, et al.Journal of Cellular and Molecular Medicine|May 10, 2008
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapyTao Chen, Mian Li, Ruiwen Zhang, et al.International Journal of Oncology|May 10, 2007
Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53Elizabeth R Rayburn, Wei Wang, Ruiwen Zhang, et al.Current Medicinal Chemistry. Anti-Cancer Agents|July 30, 2004
Recent advances in experimental molecular therapeutics for malignant gliomasGautam Prasad, Hui Wang, Donald L Hill, et al.Pageof 2,043